Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma
Journal of Hematology · 2022
DOI: 10.14740/jh1007 ↗At a glance
Journal article in Journal of Hematology, 2022. Written by Matthew Crabtree and 2 co-authors. Institution: Department of Pathology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA. Cited 6 times so far (Crossref). The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Multiple myeloma (MM) is a genetically heterogeneous disease, with cytogenetic findings that determine disease behavior. Genetic abnormalities can be assessed by fluorescence in situ hybridization (FISH) analysis and/or G-banded karyotyping. The two methods produce unique and overlapping information, and the clinical utility of using both is investigated here.
Methods
Seventy patients diagnosed with MM at a hospital in Southern California were retrospectively reviewed for the FISH and G-banded karyotyping results obtained from bone marrow specimens.
Results
Karyotype was normal in 71% (50/70), abnormal in 27% (19/70), and inadequate in 1% (1/70). Among patients with abnormal karyotype, FISH provided additional information about genetic aberrations in 95% of cases (18/19). Among cases with abnormal FISH, karyotype provided additional information about genetic aberrations in 27% of cases (18/66). When numerical abnormalities were present (detected by FISH and/or karyotype), FISH detected them in 95% (54/57), of which karyotype missed 70% (38/54) of the time. Karyotyping detected numerical abnormalities in 33% (19/57), which FISH missed 16% (3/19) of the time.
Conclusions
Karyotyping and FISH analysis in MM each provide unique information. For most patients, performing both tests together will provide more information than either test alone.
Subjects
Author keywords
Authors and institutions
- Department of Pathology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
ORCID profiles: Matthew Crabtree, Jennifer Cai, Xin Qing
Cite
APA
Crabtree, M., Cai, J., & Qing, X. (2022). Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma. Journal of Hematology. https://doi.org/10.14740/jh1007
Vancouver
Crabtree M, Cai J, Qing X. Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma. Journal of Hematology. 2022. doi:10.14740/jh1007
BibTeX
@article{Crabtree2022,
author = {Crabtree, Matthew and Cai, Jennifer and Qing, Xin},
title = {Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma},
journal = {Journal of Hematology},
year = {2022},
doi = {10.14740/jh1007}
}
EUVIMED